Novo Nordisk declined to comment on when the company would end production of human insulin pens, adding that the pens were different from those used for its hugely popular GLP-1 drugs, Ozempic and ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Working with the unnamed supplier, Civica has produced preliminary pens and vials ... a short-acting insulin named aspart, which Danish drugmaker Novo Nordisk produces under the brand name ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added ...

The Therapeutic Goods Administration (TGA) issued the warning on Thursday for products labelled with the batch number MPSD916 ...

March 4, 2025 South African watchdog probes Novo Nordisk and Sanofi over insulin ... possible anti-competitive practices in the human insulin pen market, the authority said on Tuesday.

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.